×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
IABP-SHOCK II-Studie: Interimsanalysendgk.org/daten/AG3_HT2011_Thiele.pdf · SOAP II (CS Subgruppe) In-hospital 15/40 13/40 1.15 (0.59;2.27) Up-stream Abciximab besser Standard-Behandlung
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form